Jaguar Animal Health Stock Beta
| JAGX Stock | USD 1.04 0.04 4.00% |
Jaguar Animal Health fundamentals help investors to digest information that contributes to Jaguar Animal's financial success or failures. It also enables traders to predict the movement of Jaguar Stock. The fundamental analysis module provides a way to measure Jaguar Animal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jaguar Animal stock.
Jaguar | Beta |
Jaguar Animal Health Company Beta Analysis
Jaguar Animal's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Jaguar Animal Beta | 0.88 |
Most of Jaguar Animal's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jaguar Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Jaguar Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Jaguar Animal is extremely important. It helps to project a fair market value of Jaguar Stock properly, considering its historical fundamentals such as Beta. Since Jaguar Animal's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Jaguar Animal's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Jaguar Animal's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Jaguar Animal Health has a Beta of 0.883. This is 2.67% higher than that of the Pharmaceuticals sector and 36.47% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Jaguar Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jaguar Animal's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jaguar Animal could also be used in its relative valuation, which is a method of valuing Jaguar Animal by comparing valuation metrics of similar companies.Jaguar Animal is currently under evaluation in beta category among its peers.
Jaguar Animal Institutional Holders
Institutional Holdings refers to the ownership stake in Jaguar Animal that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Jaguar Animal's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Jaguar Animal's value.| Shares | Susquehanna International Group, Llp | 2024-06-30 | 0.0 | Ica Group Wealth Management, Llc | 2024-06-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Jane Street Group Llc | 2024-06-30 | 0.0 | Perritt Capital Management Inc. | 2024-09-30 | 0.0 | Fidelity Management And Research Company | 2024-06-30 | 0.0 | Ubs Group Ag | 2024-06-30 | 0.0 | Csenge Advisory Group, Llc | 2024-06-30 | 0.0 | Two Sigma Investments Llc | 2024-06-30 | 0.0 | Geode Capital Management, Llc | 2024-09-30 | 81.8 K | Vanguard Group Inc | 2024-09-30 | 59.5 K |
Jaguar Animal returns are very sensitive to returns on the market. As the market goes up or down, Jaguar Animal is expected to follow.
Jaguar Fundamentals
| Return On Equity | -2.91 | ||||
| Return On Asset | -0.35 | ||||
| Operating Margin | (2.65) % | ||||
| Current Valuation | 33.27 M | ||||
| Shares Outstanding | 11.8 M | ||||
| Shares Owned By Insiders | 12.02 % | ||||
| Shares Owned By Institutions | 1.95 % | ||||
| Number Of Shares Shorted | 430.73 K | ||||
| Price To Earning | (0.96) X | ||||
| Price To Book | 0.90 X | ||||
| Price To Sales | 1.20 X | ||||
| Revenue | 9.76 M | ||||
| Gross Profit | 2 M | ||||
| EBITDA | (33.13 M) | ||||
| Net Income | (41.3 M) | ||||
| Cash And Equivalents | 9.01 M | ||||
| Cash Per Share | 0.08 X | ||||
| Total Debt | 37.09 M | ||||
| Current Ratio | 1.02 X | ||||
| Book Value Per Share | 4.05 X | ||||
| Cash Flow From Operations | (33.24 M) | ||||
| Short Ratio | 1.12 X | ||||
| Earnings Per Share | 20.20 X | ||||
| Price To Earnings To Growth | (0.02) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 49 | ||||
| Beta | 0.88 | ||||
| Market Capitalization | 12.27 M | ||||
| Total Asset | 50.76 M | ||||
| Retained Earnings | (308.25 M) | ||||
| Working Capital | (8.02 M) | ||||
| Current Asset | 8.45 M | ||||
| Current Liabilities | 3.91 M | ||||
| Net Asset | 50.76 M |
About Jaguar Animal Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jaguar Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jaguar Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jaguar Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Jaguar Stock Analysis
When running Jaguar Animal's price analysis, check to measure Jaguar Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jaguar Animal is operating at the current time. Most of Jaguar Animal's value examination focuses on studying past and present price action to predict the probability of Jaguar Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jaguar Animal's price. Additionally, you may evaluate how the addition of Jaguar Animal to your portfolios can decrease your overall portfolio volatility.